Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | PPARG | P37231 | 7/20 | 0.59 |
| ▸ | PPARD | Q03181 | 7/20 | 0.59 |
| ▸ | PPARA | Q07869 | 7/20 | 0.59 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.59 |
| ▸ | FABP4 | P15090 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | TLR2 | O60603 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.59 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | PDE4A | P27815 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3693306 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL298836 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL16062125 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL18263867 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL22711540 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL22833892 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL297511 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL690625 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL159254 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL28879820 | 1.00 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688725-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACID | Wilmar International Limited (SG) | 2026-02-11 | — | — | EP | claimed |
| WO-2024205503-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACID | WILMAR INTERNATIONAL LIMITED (SG) | 2024-10-03 | — | — | WO | claimed |
| EP-2288416-B2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO IND INC (US) | 2014-12-24 | — | — | EP | claimed |
| US-8822547-B2 | Hydroalcoholic gel compositions for use with dispensers | GOJO INDUSTRIES, INC. (US) | 2014-09-02 | — | — | US | claimed |
| EP-2460560-A1 | Hydroalcoholic gel compositions for use with dispensers | Gojo Industries, Inc. (US) | 2012-06-06 | — | — | EP | claimed |
| EP-2288416-B1 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO IND INC (US) | 2012-02-29 | — | — | EP | claimed |
| US-20110144214-A1 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT | 2011-06-16 | — | — | US | claimed |
| EP-2288416-A2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO Industries, Inc. (US) | 2011-03-02 | — | — | EP | claimed |
| WO-2009058802-A2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO INDUSTRIES, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| US-20260047987-A1 | BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR | DAICEL CORPORATION (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-4688725-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACID | Wilmar International Limited (SG) | 2026-02-11 | — | — | EP | disclosed |
| US-20250205122-A1 | BIODEGRADABLE FLATTENED PARTICLES, COSMETICS COMPOSITION AND METHOD FOR PRODUCING BIODEGRADABLE FLATTENED PARTICLES | DAICEL CORPORATION (JP) | 2025-06-26 | — | — | US | disclosed |
| US-20250109281-A1 | CELLULOSE ACETATE COMPOSITION | DAICEL CORPORATION (JP) | 2025-04-03 | — | — | US | disclosed |
| US-20250073134-A1 | BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR | DAICEL CORPORATION (JP) | 2025-03-06 | — | — | US | disclosed |
| WO-2003099981-A1 | METHODS AND ARTICLES FOR REDUCING AIRBORNE PARTICULATES | THE PROCTER & GAMBLE COMPANY (US) | 2003-12-04 | — | — | WO | disclosed |
| US-20030224030-A1 | Methods and articles for reducing airborne particulates | THE PROCTER & GAMBLE COMPANY | 2003-12-04 | — | — | US | disclosed |
| EP-1256336-A2 | Two-phase gel composition | Penreco (US) | 2002-11-13 | — | — | EP | disclosed |
| US-20020055562-A1 | Gel compositions | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2002-05-09 | — | — | US | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144214-A1 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | ADH1A, ADH1C, ADH5 | GPR84 1073/4885PPARG 50/4885PPARD 151/4885 |
| US-20260047987-A1 | BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR | PGA5, CD68, SBDS | GPR84 3102/4885PPARG 921/4885PPARD 455/4885 |
| US-20030224030-A1 | Methods and articles for reducing airborne particulates | CUTA, EXOSC9, PPARA | GPR84 3088/4885PPARG 38/4885PPARD 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.